Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Jun 22, 2010

Probactive and Vietnamese Organization to Combine Antibodies with Radioactive Compounds for Cancer

  • Probactive Biotech and Vietnamese organization Dalat Nuclear Research Institute are collaborating to develop cancer drugs that combine antitumor antibodies and radioactive compounds.

    Probactive Biotech says that it has combined medical-grade iodine-131 and yttrium-90 with antitumor antibodies, producing targeted anticancer activity.

    Parts of the R&D program will be completed at the Dalat Nuclear Research Institute. Clinical trials will be conducted in Vietnam under the regulatory guidelines of the Ministry of Health and also in compliance with FDA regulations.

     



Related content

Be sure to take the GEN Poll

CRISPR Patent Controversy

Do you think recently released email from a former Broad Institute scientist to Jennifer Doudna will expedite a final legal decision on who owns the CRISPR patent?

More »